Nelson Capital Management LLC Boosts Holdings in Procter & Gamble Company (The) $PG

Nelson Capital Management LLC raised its holdings in Procter & Gamble Company (The) (NYSE:PG) by 0.7% in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 49,459 shares of the company’s stock after buying an additional 323 shares during the period. Procter & Gamble makes up approximately 1.0% of Nelson Capital Management LLC’s portfolio, making the stock its 20th largest position. Nelson Capital Management LLC’s holdings in Procter & Gamble were worth $7,880,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Kingstone Capital Partners Texas LLC lifted its stake in Procter & Gamble by 655,209.0% in the second quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company’s stock worth $11,832,680,000 after acquiring an additional 76,017,350 shares during the last quarter. Nuveen LLC purchased a new stake in shares of Procter & Gamble during the 1st quarter worth approximately $1,954,941,000. Price T Rowe Associates Inc. MD lifted its position in Procter & Gamble by 13.0% in the first quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company’s stock valued at $3,660,737,000 after acquiring an additional 2,466,308 shares during the last quarter. Invesco Ltd. lifted its stake in Procter & Gamble by 19.8% in the first quarter. Invesco Ltd. now owns 13,493,604 shares of the company’s stock valued at $2,299,580,000 after buying an additional 2,228,151 shares during the last quarter. Finally, Valeo Financial Advisors LLC raised its position in Procter & Gamble by 1,875.5% in the 2nd quarter. Valeo Financial Advisors LLC now owns 1,763,404 shares of the company’s stock valued at $280,946,000 after purchasing an additional 1,674,139 shares during the last quarter. Hedge funds and other institutional investors own 65.77% of the company’s stock.

Procter & Gamble Stock Up 1.5%

PG opened at $152.60 on Wednesday. Procter & Gamble Company has a 12 month low of $149.91 and a 12 month high of $180.43. The business has a 50-day moving average of $155.30 and a two-hundred day moving average of $159.79. The stock has a market capitalization of $357.16 billion, a price-to-earnings ratio of 23.44, a price-to-earnings-growth ratio of 4.13 and a beta of 0.36. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.70 and a quick ratio of 0.49.

Procter & Gamble (NYSE:PG) last released its earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.42 by $0.06. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The firm had revenue of $20.89 billion during the quarter, compared to the consensus estimate of $20.79 billion. During the same period in the previous year, the firm earned $1.40 earnings per share. Procter & Gamble’s revenue was up 1.7% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, research analysts expect that Procter & Gamble Company will post 6.91 earnings per share for the current year.

Insider Activity at Procter & Gamble

In other news, CFO Andre Schulten sold 4,252 shares of the business’s stock in a transaction dated Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total transaction of $647,281.96. Following the completion of the sale, the chief financial officer owned 53,992 shares in the company, valued at approximately $8,219,202.16. The trade was a 7.30% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Jennifer L. Davis sold 3,227 shares of the business’s stock in a transaction dated Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total value of $491,246.21. Following the sale, the chief executive officer owned 61,764 shares of the company’s stock, valued at $9,402,333.72. The trade was a 4.97% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 149,763 shares of company stock worth $23,421,279. 0.20% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on the stock. Weiss Ratings restated a “hold (c+)” rating on shares of Procter & Gamble in a research report on Saturday, September 27th. Evercore ISI restated an “in-line” rating and issued a $170.00 price target (down previously from $190.00) on shares of Procter & Gamble in a research report on Monday, July 14th. Berenberg Bank raised their price objective on shares of Procter & Gamble from $152.00 to $154.00 and gave the stock a “hold” rating in a research note on Wednesday, September 17th. JPMorgan Chase & Co. reiterated a “neutral” rating and set a $170.00 price objective (down previously from $178.00) on shares of Procter & Gamble in a research report on Friday, July 25th. Finally, BNP Paribas reiterated an “outperform” rating and set a $177.00 price objective on shares of Procter & Gamble in a research report on Friday, August 15th. Eleven analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company’s stock. According to MarketBeat.com, Procter & Gamble has a consensus rating of “Moderate Buy” and a consensus price target of $173.11.

About Procter & Gamble

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.